DrugDashboards

Fluconazole

Fluconazole · FLUCONAZOLE 40 mg/mL · Powder, For Suspension · Oral · Zhejiang Poly Pharm. Co., Ltd.

NDC 72673-0091-14 · 1 BOTTLE in 1 CARTON / 35 mL in 1 BOTTLE · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 57237-0150-35) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$0.8030per unit
middle half $0.5322$0.9967 · 5,496 plans · Apr 1, 2026
Est. net of rebates
≈ $0.8030
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 2 · prior auth 0% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for fluconazole (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA215738
TE code
AB
Approval date
Sep 21, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Fluconazole (Powder, For Suspension)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedFLUCONAZOLE 40 mg/mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedFLUCONAZOLE 10 mg/mLJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FLUCONAZOLE 10 mg/mLJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FLUCONAZOLE 40 mg/mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCFLUCONAZOLE 10 mg/mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCFLUCONAZOLE 40 mg/mLJul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.FLUCONAZOLE 10 mg/mLJul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.FLUCONAZOLE 40 mg/mLJul 15, 2026Sep 2, 2026
RoerigFLUCONAZOLE 1400 mg/35mLJul 15, 2026Sep 2, 2026
Slate Run PharmaceuticalsFLUCONAZOLE 40 mg/mLJul 15, 2026Sep 2, 2026
Zhejiang Poly Pharm. Co., Ltd.FLUCONAZOLE 40 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fluconazole — NDC 72673-0091-14," retrieved September 3, 2026, https://drugdashboards.com/drug/72673009114.

Free to cite with attribution — see how the data is put together.